These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 2144361
21. Steroid receptors in breast cancer. Desombre ER. Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [Abstract] [Full Text] [Related]
22. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors]. Pouillart P, Madgelenat H, Jouve M, Palangie T, Garcia-Giralt E, Bretaudeau B, Polijcak M, Asselain B. Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808 [Abstract] [Full Text] [Related]
32. Maintenance of prolactin receptors in human breast cancer. Ben-David M, Dror Y, Biran S. Isr J Med Sci; 1981; 17(9-10):965-9. PubMed ID: 6273360 [Abstract] [Full Text] [Related]
35. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol. Khan SA, Sachdeva A, Naim S, Meguid MM, Marx W, Simon H, Halverson JD, Numann PJ. Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):867-72. PubMed ID: 10548314 [Abstract] [Full Text] [Related]
36. A prospective study of estradiol and breast cancer in Japanese women. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE. Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):575-9. PubMed ID: 10868691 [Abstract] [Full Text] [Related]
37. Prolactin receptor expression in gynaecomastia and male breast carcinoma. Ferreira M, Mesquita M, Quaresma M, André S. Histopathology; 2008 Jul; 53(1):56-61. PubMed ID: 18613925 [Abstract] [Full Text] [Related]
38. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma. Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T. Cancer; 2001 May 15; 91(10):1854-61. PubMed ID: 11346866 [Abstract] [Full Text] [Related]
39. [Use of protamine sulfate in a method for determining the hormonal sensitivity of breast cancer]. Degtiar' VG, Denisov LE, Iarygin LM, Khotchenkova NV. Vopr Onkol; 1985 May 15; 31(1):51-5. PubMed ID: 3976194 [Abstract] [Full Text] [Related]
40. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486). Milewicz T, Gregoraszczuk EL, Sztefko K, Augustowska K, Krzysiek J, Ryś J. Growth Horm IGF Res; 2005 Apr 15; 15(2):140-7. PubMed ID: 15809018 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]